Leonard Bell is Director at ALEXION PHARMACEUTICALS INC (ALXN). They have made 49 open-market trades across 1 company since 2006, most recently 2017-03-01.
CIK 0000899866
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 49 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALXN | 391,910 | $71.5M |
Shares reported on the most recent Form 4, priced at the 2017-03-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXN | SELL | 2017-02-28 | 2017-03-01 | $131.86 | $886K | -6.7% | -9.4% | -26.9% |
| ALXN | SELL | 2017-02-09 | 2017-02-10 | $126.84 | $31K | +2.5% | -1.9% | -6.4% |
| ALXN | SELL | 2017-02-06 | 2017-02-08 | $125.97 | $2.2M | +2.4% | +0.4% | -1.7% |
| ALXN | SELL · 10b5-1 | 2017-01-10 | 2017-01-13 | $144.99 | $14K | -5.9% | -6.2% | -13.1% |
| ALXN | SELL | 2017-01-09 | 2017-01-09 | $144.93 | $703K | -9.0% | -12.8% | -19.0% |
| ALXN | SELL | 2017-01-05 | 2017-01-09 | $138.48 | $5.5M | -9.0% | -12.8% | -19.0% |
| ALXN | SELL | 2017-01-05 | 2017-01-09 | $137.52 | $4.7M | -9.0% | -12.8% | -19.0% |
| ALXN | SELL | 2016-11-04 | 2016-11-07 | $140.38 | $5.2M | +2.7% | +4.9% | +7.0% |
| ALXN | SELL | 2016-11-04 | 2016-11-07 | $141.09 | $3.5M | +2.7% | +4.9% | +7.0% |
| ALXN | SELL | 2016-10-31 | 2016-11-02 | $135.30 | $221K | -6.9% | -3.8% | +2.3% |
| ALXN | SELL | 2016-08-08 | 2016-08-10 | $137.14 | $139K | +2.8% | -6.0% | -10.2% |
| ALXN | SELL | 2016-08-08 | 2016-08-10 | $137.14 | $139K | +2.8% | -6.0% | -10.2% |
| ALXN | SELL | 2016-02-29 | 2016-03-01 | $138.92 | $1.1M | -6.9% | -6.9% | +0.9% |
| ALXN | SELL | 2016-02-08 | 2016-02-08 | $138.02 | $1.5M | +6.5% | +2.6% | +4.8% |
| ALXN | SELL | 2016-02-05 | 2016-02-08 | $141.38 | $84K | +6.5% | +2.6% | +4.8% |
| ALXN | SELL | 2016-02-04 | 2016-02-08 | $139.58 | $2.2M | +6.5% | +2.6% | +4.8% |
| ALXN | SELL | 2016-02-04 | 2016-02-08 | $143.81 | $320K | +6.5% | +2.6% | +4.8% |
| ALXN | SELL · 10b5-1 | 2015-12-24 | 2015-12-29 | $190.66 | $6.7M | -15.6% | -22.1% | -29.1% |
| ALXN | SELL · 10b5-1 | 2015-12-17 | 2015-12-21 | $187.69 | $13.1M | -15.6% | -14.5% | -29.9% |
| ALXN | SELL | 2015-12-11 | 2015-12-15 | $187.56 | $4.0M | -15.6% | -10.5% | -28.1% |
| ALXN | SELL · 10b5-1 | 2015-12-08 | 2015-12-08 | $188.20 | $13.2M | -15.6% | -6.8% | -20.0% |
| ALXN | SELL · 10b5-1 | 2015-11-25 | 2015-11-30 | $181.89 | $6.4M | -15.6% | -1.2% | -24.7% |
| ALXN | SELL · 10b5-1 | 2015-11-02 | 2015-11-04 | $180.12 | $6.3M | -15.6% | -1.2% | -26.5% |
| ALXN | SELL · 10b5-1 | 2015-09-09 | 2015-09-10 | $180.10 | $189K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2015-08-07 | 2015-08-11 | $190.01 | $191K | -15.6% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.